The thymia team is comprised of highly qualified professionals who bring an exceptional blend of academic excellence, clinical experience and specialised skills to our app development process. Our team members hold advanced degrees, including PhDs in fields such as Neuroscience, Theoretical Physics and Computational Neuroscience. They have extensive experience in digital health diagnostics, psychology and psychiatry.

At the core of thymia is Dr Emilia Molimpakis, our Co-Founder and CEO. Emilia is the driving force behind thymia, bringing her vision of advancing mental health care to life. With a PhD and post-doctoral research from UCL in Linguistics, Cognitive Neuroscience and Psychology, Emilia is a leading expert in her field. Recognised as one of the top scientists for mental health worldwide, she has won Innovate UK’s Young Innovators Award 2020-21, delivered a TED Talk, and been featured in numerous podcasts, articles and conferences. Emilia's work places her among a select few globally who specialise in this niche area of mental health technology.

Dr Nicholas Cummins, our Chief Scientific Officer (CSO), exemplifies thymia's blend of expertise. Dr Cummins is a Lecturer in AI for Speech Analysis for Health at the Department of Biostatistics and Health Informatics at King’s College London. His research focuses on translating speech processing into clinical research and practice, particularly for mental health disorders. Dr Cummins has co-authored over 200 conference and journal papers, leading to over 6,700 citations (h-index: 43). He is a frequent reviewer for IEEE, ACM, and ISCA journals and conferences and serves on programme and organisational committees. He is also an associate editor of the Computer, Speech, and Language journal.

Our commitment to advancing mental health care is evident through our strong foundation in academic and clinical research. Our team has published over 200 peer-reviewed publications in reputable specialist journals. We are excited to share that we have several new papers currently under review, further contributing to the field of digital mental health.

As well as studies evaluating the effectiveness of speech and behaviour models for tracking mental health and mental wellness, our team has published original research on detecting potential biases in these models - demonstrating our dedication to rigorous and ethical AI science.

Click here to explore our publications and research findings.

We prioritise transparency and rigour in our research by registering our clinical studies on reputable platforms such as the International Standard Randomised Controlled Trial Number (ISRCTN) registry.

We believe in the power of collaboration and the importance of clinician feedback in developing our digital health product. To ensure our features are safe, effective, and meet diverse needs, we conduct extensive feedback sessions with clinicians from various backgrounds, including general practitioners (GPs), psychiatrists and therapists. Their insights are invaluable in refining our product, ensuring it aligns with clinical best practices and improves patient outcomes. By actively involving clinicians, we confidently deliver a tool that is both innovative and grounded in real-world experience.

At thymia we are committed to ensuring that our tools are rigorously tested and checked. Our testing is both in controlled studies and in partnership with clinics worldwide, including in the USA and Brazil.

Our clinical product is currently being prepared for rigorous evaluation and certification (UKCA, CE, and FDA). For our wellness product, which operates in the non-regulated space, we have taken comprehensive steps to ensure its safety and efficacy. We comply with relevant standards and guidelines, such as ISO/IEC 27001:2022 and the APA evaluation framework, demonstrating our commitment to maintaining high standards even beyond regulatory requirements.

thymia's innovative approach to mental health has been recognised by leading global media outlets including Forbes, The Times, Business Insider, The Telegraph, The Washington Post and more. Our evidence-based approach and commitment to transforming mental healthcare has captured attention worldwide.

Click here to explore our latest press coverage.

At thymia, our mission is to transform mental health care through cutting-edge technology, rigorous research and collaborative clinical expertise. We are dedicated to offering tools that are both scientifically advanced and user-friendly, ensuring that mental health assessments are accurate, objective and accessible to everyone, everywhere. Our commitment to continuous improvement and excellence reflects our goal to make a meaningful difference in the lives of individuals globally, empowering them with the insights and support they need to thrive.